About ChromaTan
ChromaTan is a Healthcare company based in State College (United States) founded in 2009. Continuous countercurrent tangential chromatography separation technology is developed. ChromaTan has raised $5.32 million across 8 funding rounds from investors including NIH, HHS and Ben Franklin Technology Partners. ChromaTan offers products and services including Kascade BioRMB. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography. Its legal entity is ChromaTan Inc. Its competitors include Sepax Technologies, Semba Biosciences and Sepragen; 3 of its 3 listed competitors have raised funding.
Company details
ChromaTan was founded in 2009 in State College, United States, focusing on biomanufacturing separation processes. A column-free, single-use continuous countercurrent tangential chromatography (CCTC) platform has been developed as an alternative to traditional column methods. Endorsements for the technology have been received from MedImmuneAstraZeneca, Regeneron, and NRC Canada. A 2.5 million contract from the FDA was awarded in September 2017 to advance continuous purification for single-use bio-manufacturing.
- Headquarters State College, United States
- SectorsHealthcare
- Website chromatan.com
- Social LinkedIn
- Legal Name Chromatan Inc.
- Total Equity Funding$5.32M (USD)
in 8 rounds
- Latest Funding Round$2M (USD), Grant
May 2024
- InvestorsNIH
& 6 more
Products & Services of ChromaTan
ChromaTan offers a comprehensive portfolio of products and services, including Kascade BioRMB.
Column-free system for efficient bioprocessing and purification of modalities.
Funding Insights of ChromaTan
ChromaTan has successfully raised a total of $5.32M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.32M
- Total Rounds 8
- Last Round Grant — $2M
- First Round $183,000
(Aug 2011)
- Investors Count 7
All 8 funding rounds of ChromaTan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $2M | Grant | – | – | |
| May 2024 | $1.52M | Grant | – | – | |
| Jun 2019 | $2.72M | Series A | – | – | – |
| Sep 2017 | $2.5M | Series A | – | – | |
| Apr 2017 | $100,000 | Seed | – | – | |
| Mar 2017 | $4.45M | Grant | – | – | |
| Sep 2011 | $1.36M | Grant | – | – | |
| Aug 2011 | $183,000 | Grant | – | – |
7 investors in total: 7 institutional.
Investors in ChromaTan
ChromaTan has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| sbir.nih.gov | ||||
Investment and support are provided for Pennsylvania's tech-based companies. | 1983 | benfranklin.org | State College, United States | |
Early-stage investments are made in life sciences technologies. | lsgpa.com | Harrisburg, United States | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| bluetreeventurefund.com |
Investor details for ChromaTan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ChromaTan
3 people are tracked at ChromaTan (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Oleg Shinkazh | Founder And CTO | Leadership |
Thiago Millen | Associate Director Of Process Development | Leadership |
Dwayne A. Kenney II | Senior Associate Scientist, Process And Analytics | Team |
Complete people profiles for ChromaTan
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ChromaTan
3 dated milestones of ChromaTan across 15 years, from founding to its latest funding, stage changes and deals.
- Founded ChromaTan is founded.
- Funding First funding round of $183K.
- Funding Latest funding round, Grant, of $2.0M.
Competitors of ChromaTan
ChromaTan has 3 listed competitors in our database, 3 of them funded. They include Sepax Technologies, Semba Biosciences and Sepragen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| sembabio.com | 2005 | Madison, United States | $5.85M | Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC) | ||
| sepragen.com | 1987 | Hayward, United States | $5M | 19 | Biomolecular separation technologies are enabled for bioprocessing applications. |
Detailed competitors of ChromaTan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ChromaTan
Websites that share an audience with ChromaTan (chromatan.com).
Websites whose visitors overlap most with ChromaTan. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mail.google.com | mail.google.com | 100% | – | ||
bioprocessingsummit.com | bioprocessingsummit.com | 77% | #3,841,672 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ChromaTan (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chromatan
Complete news archive for ChromaTan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChromaTan
ChromaTan was founded in 2009 and raised its 1st funding round 2 years after it was founded.
ChromaTan is headquartered in State College, United States. It is registered at State College, Pennsylvania, United States.
ChromaTan is a funded company, having raised a total of $5.32M across 8 funding rounds to date. The company's 1st funding round was a Grant of $183K, raised on Aug 2011.
ChromaTan was founded in 2009 in State College, United States, focusing on biomanufacturing separation processes. A column-free, single-use continuous countercurrent tangential chromatography (CCTC) platform has been developed as an alternative to traditional column methods. Endorsements for the technology have been received from MedImmuneAstraZeneca, Regeneron, and NRC Canada. A 2.5 million contract from the FDA was awarded in September 2017 to advance continuous purification for single-use bio-manufacturing.
ChromaTan's top competitors include Sepragen, Sepax Technologies and Semba Biosciences.
ChromaTan offers Kascade BioRMB.
ChromaTan has 7 investors. Key investors include NIH, HHS, Ben Franklin Technology Partners, NIH SBIR/STTR, and LSG Investments.
ChromaTan operates through Chromatan Inc..